SCHEMBL23146337

SCHEMBL23146337

CC1(C)OCC(Cc2ccc(CO)cc2)O1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TMEM97 Q5BJF2 2/20 0.45
SIGMAR1 Q99720 2/20 0.45
CA2 P00918 2/20 0.37
ALDH1A1 P00352 4/20 0.37
NPSR1 Q6W5P4 1/20 0.37
NAMPT P43490 3/20 0.36
KDM4E B2RXH2 2/20 0.34
HPGD P15428 2/20 0.34
HSD17B10 Q99714 2/20 0.34
MEN1 O00255 1/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
MAPT P10636 1/20 0.34
PKM P14618 1/20 0.34
ALOX15 P16050 1/20 0.34
MAPK1 P28482 1/20 0.34
CASP1 P29466 1/20 0.34
BLM P54132 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1081573 0.87 TMEM97 (0.45) TMEM97SIGMAR1CA2ALDH1A1NPSR1
SCHEMBL1081575 0.87 TMEM97 (0.45) TMEM97SIGMAR1CA2ALDH1A1NPSR1
SCHEMBL8977956 0.85 ALDH1A1 (0.43) TMEM97SIGMAR1CA2ALDH1A1NPSR1
Benzyl Alcohol SCHEMBL16651422 0.84 SIGMAR1 (0.52) TMEM97SIGMAR1CA2ALDH1A1NAMPT
SCHEMBL2458179 0.83 TMEM97 (0.42) TMEM97SIGMAR1CA2ALDH1A1NPSR1
SCHEMBL23146060 0.83 SIGMAR1 (0.42) TMEM97SIGMAR1CA2ALDH1A1NPSR1
SCHEMBL1747643 0.83 TMEM97 (0.42) TMEM97SIGMAR1CA2ALDH1A1NPSR1
SCHEMBL11105943 0.83 TMEM97 (0.56) TMEM97SIGMAR1CA2ALDH1A1NPSR1
SCHEMBL10757960 0.80 TMEM97 (0.46) TMEM97SIGMAR1CA2ALDH1A1NPSR1
SCHEMBL22705180 0.80 CA2 (0.42) TMEM97SIGMAR1CA2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220380370-A1 XANTHINE CB1 INHIBITORS GFB (ABC), LLC 2022-12-01 US disclosed
EP-4034101-A1 XANTHINE CB1 INHIBITORS Goldfinch Bio, Inc. (US) 2022-08-03 EP disclosed
CN-114727983-A Xanthine CB1 inhibitors 金翅雀生物公司 2022-07-08 CN disclosed
WO-2021062089-A1 XANTHINE CB1 INHIBITORS GOLDFINCH BIO, INC. (US) 2021-04-01 WO disclosed
WO-2021062089-A1 XANTHINE CB1 INHIBITORS GOLDFINCH BIO, INC. (US) 2021-04-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220380370-A1 XANTHINE CB1 INHIBITORS CNR1, GPR119, CNR2 TMEM97 1491/4885SIGMAR1 792/4885CA2 4711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.